Stock 2315 BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

Equities

2315

CNE100005D27

End-of-day quote Hong Kong S.E.
Other stock markets
 06:00:00 2024-07-10 pm EDT 		5-day change 1st Jan Change
7.59 CNY +1.88% Intraday chart for Biocytogen Pharmaceuticals (Beijing) Co., Ltd. +1.61% -36.64%
Jun. 04 XtalPi Inc. announced that it has received CNY 337 million in funding from Shanghai Guosheng Investment Group, Biocytogen Pharmaceuticals Co., Ltd., FaaS Capital Longevity Limited and other investors CI
May. 06 Biocytogen Enters into Evaluation and Potential Licensing Agreement with Biocopy for TCR-mimic Antibodies CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD.
Other Biotechnology & Medical Research
+1.88%+1.61%-36.64%-62.52% - 388M
Bearish
Bearish
Bearish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. 2315 Stock
  4. Charts Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
  5. Comparison Chart